Title | Type | SJR | H index | Total Docs. (2001) | Total Docs. (3years) | Total Refs. (2001) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2001) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
148 | American Druggist | journal | 0.100 Q4 | 3 | 0 | 109 | 0 | 1 | 85 | 0.00 | 0.00 | |
147 | Clin-Alert | journal | 0.101 Q4 | 0 | 0 | 24 | 0 | 0 | 24 | 0.00 | 0.00 | |
146 | Journal of Pharmacy Technology | journal | 0.104 Q4 | 16 | 54 | 145 | 598 | 8 | 89 | 0.07 | 11.07 | |
145 | Pharmaceutical Chemistry Journal | journal | 0.104 Q4 | 39 | 187 | 491 | 2945 | 11 | 489 | 0.03 | 15.75 | |
144 | Adverse Drug Reaction Bulletin | journal | 0.106 Q4 | 8 | 6 | 18 | 150 | 4 | 18 | 0.25 | 25.00 | |
143 | Drug Topics | journal | 0.106 Q4 | 8 | 321 | 1796 | 0 | 44 | 1283 | 0.03 | 0.00 | |
142 | Journal of Medical Marketing | journal | 0.111 Q4 | 20 | 31 | 28 | 327 | 1 | 25 | 0.04 | 10.55 | |
141 | Clinical Research and Regulatory Affairs | journal | 0.117 Q4 | 18 | 23 | 49 | 1132 | 6 | 46 | 0.11 | 49.22 | |
140 | Pharmaceutical Engineering | journal | 0.117 Q4 | 18 | 34 | 138 | 292 | 10 | 131 | 0.07 | 8.59 | |
139 | National Toxicology Program technical report series | journal | 0.121 | 22 | 7 | 1 | 0 | 0 | 1 | 0.00 | 0.00 | |
138 | Research Communications in Pharmacology and Toxicology | journal | 0.123 Q4 | 8 | 26 | 47 | 579 | 8 | 47 | 0.23 | 22.27 | |
137 | Therapeutic Innovation and Regulatory Science | journal | 0.123 Q3 | 51 | 241 | 775 | 3805 | 255 | 762 | 0.31 | 15.79 | |
136 | Proceedings of the Western Pharmacology Society | journal | 0.129 Q4 | 25 | 65 | 311 | 782 | 50 | 310 | 0.16 | 12.03 | |
135 | Pharmaceutical Technology Europe | journal | 0.135 Q3 | 19 | 73 | 249 | 363 | 41 | 187 | 0.17 | 4.97 | |
134 | Dissolution Technologies | journal | 0.141 Q3 | 36 | 13 | 44 | 70 | 18 | 24 | 0.55 | 5.38 | |
133 | Proceedings of the Controlled Release Society | journal | 0.141 Q3 | 14 | 0 | 1102 | 0 | 129 | 1102 | 0.12 | 0.00 | |
132 | Research Communications in Alcohol and Substances of Abuse | journal | 0.149 Q4 | 5 | 4 | 20 | 111 | 6 | 20 | 0.42 | 27.75 | |
131 | Hospital Pharmacy | journal | 0.156 Q4 | 28 | 166 | 474 | 1625 | 84 | 399 | 0.19 | 9.79 | |
130 | Journal of Infectious Disease Pharmacotherapy | journal | 0.158 Q3 | 6 | 27 | 29 | 776 | 6 | 28 | 0.17 | 28.74 | |
129 | Journal of Herbs, Spices and Medicinal Plants | journal | 0.159 Q3 | 34 | 25 | 92 | 1096 | 32 | 90 | 0.17 | 43.84 | |
128 | Journal of Research in Pharmaceutical Economics | journal | 0.159 Q3 | 6 | 30 | 26 | 611 | 6 | 25 | 0.00 | 20.37 | |
127 | Journal of Pharmacoepidemiology | journal | 0.166 Q3 | 5 | 0 | 11 | 0 | 1 | 9 | 0.09 | 0.00 | |
126 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.167 Q3 | 29 | 20 | 24 | 1058 | 8 | 22 | 0.27 | 52.90 | |
125 | Pharmacopeial Forum (discontinued) | journal | 0.174 Q3 | 20 | 9 | 41 | 184 | 11 | 41 | 0.08 | 20.44 | |
124 | AAPS Journal | journal | 0.185 Q3 | 132 | 72 | 101 | 2219 | 63 | 101 | 0.62 | 30.82 | |
123 | International Journal of Toxicology | journal | 0.191 Q4 | 71 | 80 | 196 | 2812 | 60 | 182 | 0.20 | 35.15 | |
122 | BioPharm International | trade journal | 0.204 Q2 | 32 | 136 | 305 | 666 | 61 | 264 | 0.22 | 4.90 | |
121 | American Journal of Pharmaceutical Education | journal | 0.216 Q2 | 78 | 56 | 207 | 901 | 59 | 207 | 0.30 | 16.09 | |
120 | Modern Drug Discovery | journal | 0.219 Q2 | 9 | 19 | 45 | 85 | 26 | 45 | 0.56 | 4.47 | |
119 | Veterinary and Human Toxicology | journal | 0.220 Q3 | 43 | 98 | 333 | 1574 | 208 | 313 | 0.62 | 16.06 | |
118 | In Vitro and Molecular Toxicology: Journal of Basic and Applied Research | journal | 0.238 Q3 | 22 | 23 | 97 | 659 | 55 | 86 | 0.53 | 28.65 | |
117 | Artificial Cells, Nanomedicine and Biotechnology | journal | 0.245 Q2 | 86 | 37 | 215 | 787 | 122 | 204 | 0.73 | 21.27 | |
116 | Current Therapeutic Research | journal | 0.248 Q3 | 46 | 86 | 279 | 2284 | 149 | 235 | 0.57 | 26.56 | |
115 | CNS Drug Reviews | journal | 0.254 Q3 | 64 | 23 | 96 | 2299 | 60 | 96 | 0.61 | 99.96 | |
114 | Research Communications in Molecular Pathology and Pharmacology | journal | 0.259 Q3 | 40 | 61 | 297 | 1450 | 183 | 296 | 0.54 | 23.77 | |
113 | Natural Toxins | journal | 0.285 Q3 | 49 | 0 | 86 | 0 | 114 | 84 | 1.09 | 0.00 | |
112 | Journal of the American Pharmacists Association : JAPhA | journal | 0.286 Q3 | 73 | 110 | 340 | 950 | 271 | 319 | 0.82 | 8.64 | |
111 | Cardiovascular Drug Reviews | journal | 0.299 Q3 | 54 | 25 | 80 | 1597 | 59 | 80 | 0.52 | 63.88 | |
110 | American Journal of Therapeutics | journal | 0.300 Q3 | 69 | 58 | 171 | 330 | 125 | 151 | 0.76 | 5.69 | |
109 | Birth Defects Research Part B - Developmental and Reproductive Toxicology | journal | 0.307 Q3 | 58 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
108 | Journal of Pharmacological and Toxicological Methods | journal | 0.311 Q3 | 83 | 49 | 185 | 1674 | 168 | 183 | 0.67 | 34.16 | |
107 | Addiction Biology | journal | 0.315 Q3 | 93 | 39 | 136 | 1371 | 97 | 134 | 0.59 | 35.15 | |
106 | Pharmaceutical Technology | journal | 0.315 Q2 | 42 | 104 | 325 | 1009 | 110 | 299 | 0.27 | 9.70 | |
105 | Journal of Natural Toxins | journal | 0.321 Q3 | 28 | 32 | 87 | 731 | 92 | 87 | 1.02 | 22.84 | |
104 | Food and Drug Law Journal | journal | 0.336 Q2 | 23 | 25 | 140 | 1303 | 47 | 140 | 0.22 | 52.12 | |
103 | Journal of Environmental Pathology, Toxicology and Oncology | journal | 0.350 Q3 | 50 | 54 | 132 | 1834 | 112 | 130 | 0.83 | 33.96 | |
102 | Metal-Based Drugs | journal | 0.383 Q2 | 40 | 48 | 134 | 1542 | 120 | 133 | 0.90 | 32.13 | |
101 | Basic and Clinical Pharmacology and Toxicology | journal | 0.384 Q2 | 103 | 111 | 308 | 1537 | 339 | 302 | 0.94 | 13.85 | |
100 | Drug Development Research | journal | 0.391 Q3 | 67 | 130 | 282 | 1096 | 320 | 276 | 1.05 | 8.43 | |
99 | American Journal of Health-System Pharmacy | journal | 0.411 Q2 | 107 | 411 | 1396 | 3687 | 936 | 796 | 0.73 | 8.97 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®